NASDAQ:CLDX - Celldex Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$5.92 -0.07 (-1.17 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$5.92
Today's Range$5.76 - $6.07
52-Week Range$2.74 - $42.90
Volume236,662 shs
Average Volume649,260 shs
Market Capitalization$68.08 million
P/E Ratio-0.49
Dividend YieldN/A
Beta4.47

Analyst Ratings

Celldex Therapeutics (NASDAQ:CLDX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Celldex Therapeutics in the last 12 months. Their average twelve-month price target is $40.00, suggesting that the stock has a possible upside of 575.68%. The high price target for CLDX is $45.00 and the low price target for CLDX is $30.00. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.332.33
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $40.00$40.00$67.50$67.50
Price Target Upside: 575.68% upside15,284.62% upside1,263.64% upside15,597.67% upside

Celldex Therapeutics (NASDAQ:CLDX) Consensus Price Target History

Price Target History for Celldex Therapeutics (NASDAQ:CLDX)

Celldex Therapeutics (NASDAQ:CLDX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/15/2019Bank of AmericaUpgradeNeutral ➝ BuyLowView Rating Details
11/19/2018HC WainwrightSet Price TargetBuy$30.00HighView Rating Details
8/10/2018Jefferies Financial GroupReiterated RatingHoldHighView Rating Details
8/9/2018CowenReiterated RatingHoldLowView Rating Details
4/17/2018Cantor FitzgeraldDowngradeOverweight ➝ Neutral$45.00LowView Rating Details
3/8/2018Leerink SwannReiterated RatingMarket Perform ➝ Market Perform$60.00 ➝ $45.00HighView Rating Details
12/6/2017WBB SecuritiesReiterated RatingBuy$150.00LowView Rating Details
6/29/2017AegisReiterated RatingBuyMediumView Rating Details
(Data available from 2/23/2017 forward)
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel